Doctors debate when to shield children from cancer drug's hearing damage

A new analysis examines sodium thiosulfate's ability to protect children undergoing cisplatin chemotherapy from permanent hearing loss—a common and life-altering side effect. The challenge: determining which young patients should receive the protective drug, since it's not suitable for everyone and adds complexity to treatment decisions.

Originaltitel: Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it